Center Without Walls Doctors and Researchers continued...
Peter Calebresi, MD
Peter A. Calabresi, MD is a Professor of Neurology at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center and the Division of Neuroimmunology and Neuroinfectious. As director of the MS Center Diseases at Johns Hopkins, Dr. Calabresi is the principal investigator on several clinical trials. He has designed and directed several clinical trials investigating combination drug therapies in MS and is on the advisory board for three national multi-center clinical trials. Dr. Calabresi also mentors trainees and also oversees translational laboratory research projects within the Division. His specific laboratory research interest lies in understanding how to more specifically target the disease causing effector memory T cells in MS without compromising healthy immune responses. Dr. Calabresi is also the recipient of a new five-year National MS Society collaborative center grant to study mechanisms to promote remyelination in MS.
Emmanuelle L. Waubant, MD, PhD
Dr. Emmanuelle Waubant is a Professor of Neurology at UCSF. She is a specialist in the treatment of patients with multiple sclerosis (MS). A native of France, she earned her medical degree at the University of Medicine in Lille, France, and completed her residency and chief residency at Toulouse University Hospital. Waubant completed fellowships in neuroimmunology at UCSF Medical Center and in clinical neuroimmunology at UCSF's Multiple Sclerosis Center. She then returned to France to head a clinical research center at the Pitie-Salpetriere University Hospital. She has joined the faculty at UCSF MS Center in 2001. Dr. Waubant is also one of the leading Neurologist in Pediatric MS.
Leslie Weiner, MD
Dr. Leslie Weiner is Chairman of the Department of neurology at USC and former Visiting Associate of Biology at California Institute of Technology. He has been involved in many areas of MS research. Newer work has been concentrated on the molecular and genetic mechanisms of degenerative disease of the nervous system. His most recent effort is in restoring tolerance to myelin antigens in human and mouse models. We are administering a USC T cell vaccine to multiple sclerosis patients and studying the induction of tolerance by gene therapy.